LAVA Therapeutics NV (LVTX)
NASDAQ
Quarter End | 9 2022 | 12 2022 | 3 2023 | 6 2023 | 9 2023 | 12 2023 | 3 2024 | 6 2024 |
---|---|---|---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | ||||
総売上 | 15.26M | 2.64M | 1.22M | 5.14M | 53k | 353k | 6.99M | 0 |
営業利益 | -4.71M | -11.56M | -13.54M | -13.55M | -18.31M | -15.89M | -1.95M | -9.36M |
税引前収入 | 1.06M | -14.93M | -13.87M | -12.6M | -8.79M | -6.44M | -484k | -8.21M |
純利益 | 1.02M | -15M | -13.94M | -12.7M | -8.84M | -6.5M | -553k | -8.3M |
優先配当 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
基本的1株当たり利益 (EPS) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
EBIT | -4.71M | -11.56M | -13.54M | -13.55M | -18.31M | -15.89M | -1.95M | -9.36M |
EBITDA | -5.05M | -10.78M | -13.23M | -13.25M | -18.43M | -15.1M | -1.71M | -9.13M |
年末 2023年12月31日 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
総売上 | 0 | 3.5M | 5.35M | 19.39M | 6.77M |
営業利益 | -9.58M | -14.92M | -43.61M | -34.84M | -43.25M |
税引前収入 | -9.69M | -15.46M | -42.2M | -31.66M | -41.7M |
純利益 | -9.69M | -15.51M | -42.36M | -31.91M | -41.97M |
優先配当 | 0 | 0 | 0 | 0 | 0 |
基本的1株当たり利益 (EPS) | -0.287 | -0.571 | -0.549 | -0.411 | -0.537 |
EBIT | -9.58M | -14.92M | -43.61M | -34.84M | -43.25M |
EBITDA | -9.32M | -14.46M | -43.06M | -34.06M | -41.98M |
顧客サポート: +44 (0) 203 8794 460 | support@advfn.com
ADVFNのサービスをご利用いただくには、利用規約